Related by context. All words. (Click for frequent words.) 67 pathogenic mechanisms 67 motor neuron diseases 67 myeloproliferative diseases 66 mitochondrial disorders 66 essential thrombocythemia 65 ANCA associated 64 hematologic disorders 64 immunodeficiencies 64 neuropsychiatric diseases 64 Sjögren syndrome 64 lupus multiple sclerosis 63 myeloproliferative disorders 63 ependymomas 63 FTLD 63 myopathies 63 pathophysiologic 62 proliferative disorders 62 neoplastic diseases 62 ciliopathies 62 anemias 62 histological subtypes 62 neuropsychiatric disorders 62 pathophysiological mechanisms 62 motor neuron degeneration 62 optica 62 biologies 62 neoplastic 62 immunoregulation 62 sporadic ALS 62 murine models 62 degenerative neurological diseases 62 malignant lymphomas 61 ALK mutations 61 isotypes 61 demyelinating 61 immunological diseases 61 hematopoietic malignancies 61 leukemias lymphomas 61 kidney urologic 61 fibrotic disease 61 dystrophies 61 gastrointestinal stromal tumors GISTs 61 lymphoid tumors 61 genetic syndromes 61 pathophysiological 61 neuronal dysfunction 61 glial tumors 61 inflammatory demyelinating 61 Inflammatory bowel diseases 61 Leydig cell 61 Chronic lymphocytic leukemia 61 lysosomal storage diseases 61 pilocytic astrocytomas 61 demyelinating disease 61 ataxias 61 extramedullary 61 TTR amyloidosis 61 inflammatory bowel diseases 61 muscular dystrophies 61 epithelial tumors 60 transgenic mouse models 60 underlying pathophysiology 60 neuronal stem cells 60 mitochondrial dysfunction 60 neuroinflammation 60 clinically heterogeneous 60 carcinoid 60 HbF 60 progressive neurodegenerative disorder 60 monogenic 60 hepatocellular carcinomas 60 epilepsies 60 experimental autoimmune encephalomyelitis 60 transcriptional regulation 60 etiologies 60 Myelodysplastic syndromes MDS 60 Neurodegenerative diseases 60 Leukemias 60 neuropilin 60 myelofibrosis polycythemia vera 60 erythropoiesis 60 Acute myeloid leukemia 60 ERK signaling 60 SSc 60 histologies 60 V#F mutation 60 gastric carcinoma 60 neuroendocrine cancers 60 destroys myelin 60 degenerative disorders 60 osteosarcomas 60 metaplasia 60 retroviral vectors 60 sarcomatoid 60 neuroendocrine cells 60 rheumatoid arthritis lupus 60 mGluR2 NAM 60 missense mutations 60 tumorigenicity 60 sCJD 60 lymphocytic 60 Medullary thyroid cancer 60 immunocompetent 60 anti angiogenic agents 60 cellular prion protein 60 PARP inhibition 60 myeloproliferative neoplasms 60 neurodegenerative diseases 60 neurologic disorders 60 cypin 59 neuropsychiatric disorder 59 neurotrophic 59 tumoral 59 multifactorial disease 59 metabolomic profiles 59 seminomas 59 LRRK2 mutations 59 pathogenetic 59 pancreatic endocrine 59 mediated autoimmune diseases 59 neuroendocrine 59 leukodystrophies 59 synaptogenesis 59 glomerulonephritis 59 Psoriatic arthritis 59 immune dysregulation 59 oncogenesis 59 Systemic lupus erythematosus SLE 59 oncoproteins 59 metastatic neuroendocrine tumors 59 benign neoplasms 59 epithelial cancers 59 kinase inhibition 59 arthritis RA 59 fungoides 59 molecular biomarkers 59 protein misfolding diseases 59 neovascular 59 rheumatoid arthritis multiple sclerosis 59 epithelial tissues 59 neurological manifestations 59 Parkinson disease Alzheimer disease 59 oligodendrogliomas 59 bone marrow mesenchymal stem 59 GSK3B 59 DNA methylation patterns 59 JAK inhibitors 59 biologic pathway 59 intestinal epithelium 59 lymph node enlargement 59 Magnesium deficiency 59 neurodegenerative disorder 59 myelomas 59 Prion diseases 59 carcinoids 59 hamartomas 59 myeloproliferative 59 thalassemia sickle cell 59 atypical hemolytic uremic syndrome 59 intracellular signal transduction 59 biochemical abnormalities 59 presymptomatic 59 systemic amyloidosis 59 glutamate transporter 59 coagulation disorders 59 constitutively expressed 59 haematopoietic 59 mimetics 59 VIPR2 59 Hereditary angioedema HAE 59 PTEN mutations 59 Purkinje cell 59 Myotonic dystrophy 58 Huntingtons disease 58 demyelination 58 retinal degenerative diseases 58 transgene expression 58 M. pneumoniae 58 neural tissues 58 Kupffer cells 58 molecular abnormalities 58 inherited retinal degeneration 58 progressive neurodegenerative 58 haematologic 58 GBA mutations 58 IgG4 58 biomarker assay 58 Sjogren syndrome 58 immuno modulatory 58 dominantly inherited 58 neuro degenerative diseases 58 ADPKD 58 apoptotic pathway 58 neuroendocrine tumors 58 demyelinating disorders 58 MAPK pathway 58 endogenous ligands 58 multipotent stem cells 58 lymphoma subtypes 58 familial ALS 58 leiomyoma 58 genomic variants 58 rheumatic diseases 58 prostate carcinomas 58 dyskeratosis congenita 58 tauopathies 58 neurite outgrowth 58 Parkinsonian Syndromes 58 lymphoid cells 58 granulomatous 58 epilepsy Parkinson disease 58 antitumor efficacy 58 lesional 58 ocular disorders 58 histologic subtypes 58 TMEM#B 58 neuronal signaling 58 amyloid formation 58 colorectal carcinogenesis 58 cellular pathways 58 psoriasis Crohn disease 58 synaptic function 58 Systemic lupus erythematosus 58 Inflammatory arthritis 58 sortilin 58 neuro degenerative disorders 58 etiologic 58 nociceptive pain 58 neurofibromas 58 multiple sclerosis Crohn disease 58 mesenteric 58 paraneoplastic 58 de novo mutations 58 Genetic variants 58 neurodevelopmental disorders 58 immunodeficiency disorders 58 progressive neurodegenerative disorders 58 splice variants 58 endophenotypes 58 haematological 58 GH deficiency 58 gastrointestinal dysfunction 58 mesothelial cells 58 autosomal dominant 58 idiopathic pulmonary 58 G6PD deficiency 58 astrocytomas 58 NKG2D 58 pathophysiologic mechanism 58 neuropathologic 58 rheumatoid arthritis systemic lupus 58 syndromes 58 schwannomas 58 pharmacologic intervention 58 Relapsing remitting 58 monocytic 58 muscular dystrophy cystic fibrosis 58 spongiform encephalopathies 58 choroidal neovascularization 58 Aortic stenosis 58 systemic autoimmune 58 immunopathology 58 proliferative diseases 58 androgen receptor AR 58 Systemic lupus 58 PDGFR 58 hematological diseases 58 serologic tests 58 myelination disorders 58 neurological diseases 58 NF1 58 vascular dysfunction 58 neurogenic 58 pheochromocytoma 57 TXNIP 57 periodontal tissues 57 #q#.# [002] 57 lupus scleroderma 57 pain syndromes 57 costimulatory 57 B7 H3 57 FLT3 57 Endometrial cancer 57 autoinflammatory diseases 57 aetiology 57 AAT deficiency 57 supratentorial 57 NF kB pathway 57 hematologic diseases 57 alpha synuclein protein 57 circulating endothelial cells 57 GISTs 57 Fibroblast Growth Factor Receptor 57 p# mutations 57 rheumatoid arthritis psoriasis 57 remyelination 57 hemoglobinopathies 57 N glycan 57 EBV infection 57 lysosomal storage disease 57 serous ovarian cancer 57 Myelodysplastic syndromes 57 imatinib resistance 57 cells hESCs 57 Parkinson disease multiple sclerosis 57 non coding RNA 57 herpes viruses 57 Parkinsonian 57 multiple sclerosis psoriasis 57 IgA deficiency 57 tRNA synthetases 57 prognostic marker 57 erythematosus 57 insoluble proteins 57 CagA 57 polycythemia vera PV 57 small molecule activators 57 BCL#A 57 Meningiomas 57 biologic pathways 57 Acute lymphoblastic leukemia 57 RNAi therapeutic targeting 57 Squamous 57 Myelodysplastic syndrome 57 mTOR inhibitors 57 Pulmonary arterial hypertension 57 malignant pheochromocytoma 57 myelin protective sheath 57 microRNA expression 57 miRNA molecules 57 lymphoid organs 57 lung carcinomas 57 neuroblastomas 57 posttranslational modifications 57 Hutchinson Gilford progeria 57 epithelioid 57 plexiform 57 histiocytosis 57 germline mutations 57 beta amyloid peptides 57 protein tyrosine phosphatase 57 etiologic agent 57 autoimmune hemolytic anemia 57 peptibody 57 cutaneous lesions 57 PDGF receptor 57 neurosensory 57 immunotherapeutic approaches 57 bexarotene 57 NPHP 57 neuro inflammatory 57 rheumatologic 57 pathological hallmarks 57 Transverse myelitis 57 adipose derived regenerative 57 receptor subtypes 57 antiproliferative effects 57 Hashimoto thyroiditis 57 obesity insulin resistance 57 CB2 receptor 57 autoimmune diseases 57 vitamin D receptors 57 neurological disorders 57 targets TRPM8 57 facioscapulohumeral muscular dystrophy 57 generalized vitiligo 57 susceptibility loci 57 MDR1 57 neurogenerative diseases 57 distinct subtypes 57 arterial calcification 57 nonischemic 57 EGFR inhibitors 57 mtDNA mutations 57 microdeletion 57 C. trachomatis 57 cell adhesion molecule 57 murine model 57 metastatic cancers 57 selective inhibition 57 renal diseases 57 generalized epilepsy 57 focally 57 infantile NCL 57 clade B 57 mucinous 57 Peutz Jeghers syndrome 57 untreated celiac disease 57 Interferon beta 57 STAT3 signaling 57 osteoblastic 57 TRAIL induced apoptosis 57 nephronophthisis 57 eosinophilic 57 telomere dysfunction 57 MAP kinases 57 substrate specificity 57 hematological disorders 57 inherited mutations 57 VDAs 57 gp# protein [002] 57 primary immunodeficiencies 57 beta lactamases 57 LHON 57 CYT# potent vascular disrupting 57 Diabetic neuropathy 57 frontotemporal 57 lymphangiogenesis 57 autoimmune inflammatory 57 Lipoic acid 57 lymphoproliferative disorders 57 PI3K AKT 57 autosomal dominant inheritance 57 underlying vasculopathy 57 peptide antigens 57 Bardet Biedl Syndrome 57 Symadex 57 genetic aberrations 57 intestinal inflammations 57 JAK2 enzyme 57 epigenetic alterations 56 familial clustering 56 serine proteases 56 basal cell nevus syndrome 56 prostate carcinogenesis 56 autosomal dominant polycystic kidney 56 EGFR inhibition 56 neurodegenerative disorders 56 monogenic diseases 56 rheumatoid arthritis inflammatory bowel 56 PAOD 56 hyperplastic 56 neuro developmental disorder 56 idiopathic myelofibrosis 56 Gleevec resistant 56 prostate adenocarcinoma 56 Upregulation 56 resolvins 56 Chronic myeloid leukemia 56 autoinflammatory 56 pancreatic adenocarcinoma 56 Clusterin 56 complement inhibitor eculizumab 56 childhood disintegrative disorder 56 biologic therapeutics 56 phenotypic expression 56 lymphomas leukemias 56 allelic variants 56 antimitotic 56 FGFs 56 discoid lupus 56 SMAD4 56 aMCI precursor 56 multigenic 56 chemoresistant 56 signaling cascades 56 miRNA expression 56 ocular inflammatory 56 Nedd4 56 autoantigen 56 Becker muscular dystrophy 56 TNFR 56 epithelial tissue 56 progressive degeneration 56 renal hepatic 56 pharmacological approaches 56 proliferative retinopathy 56 Xanafide 56 neurofibromatosis type 56 MEK inhibitors 56 choroidal vasculopathy 56 CTAP# Capsules 56 oncogenic transformation 56 Prostatitis 56 protein tyrosine phosphatases 56 pleiotropic 56 herpesviruses 56 beta1 integrin 56 clonal expansion 56 immune modulating 56 Autoimmune disorders 56 beta globin gene 56 Li Fraumeni Syndrome 56 synovial tissue 56 neurofibrillary 56 cerebrovascular disorders 56 molecular mechanisms underlying 56 immunoregulatory 56 Mesenchymal 56 methylation patterns 56 chemokine receptors 56 Hurler syndrome 56 circadian genes 56 histocompatibility 56 renal fibrosis 56 axonal damage 56 1 diabetes T1D 56 sd rxRNA compounds 56 immunomodulatory therapy 56 lung epithelium 56 mutated p# 56 cognitive impairment associated 56 NOMID 56 Keratitis 56 myosins 56 immunomodulation 56 glaucoma cataract 56 aetiological 56 isoenzymes 56 mammalian circadian clock 56 CEACAM1 56 hematopoietic cells 56 mechanistic studies 56 MECP2 gene 56 nonhereditary 56 Chronic lymphocytic leukemia CLL 56 pulmonary metastases 56 autoimmune disorders 56 Six3 56 pathological hallmark 56 neural crest 56 fibroma 56 Dilated cardiomyopathy 56 potent inhibitors 56 prognostic markers 56 Leber Congenital Amaurosis LCA 56 eccrine 56 NOD2 56 molecular determinants 56 rare autosomal recessive 56 PI3K inhibitors 56 carbohydrate antigens 56 essential thrombocythemia ET 56 ATG#L# 56 neurodegenerative illnesses 56 transgenic mouse model 56 autoimmune thyroid 56 antisense oligonucleotides 56 penetrance 56 intercellular communication 56 hereditary spastic paraplegia 56 molecular signaling pathways 56 transplantation HCT 56 etiologic factors 56 renal carcinoma 56 PC# cells 56 Stargardt Macular Dystrophy SMD 56 malignant pancreatic 56 rheumatoid arthritis psoriatic arthritis 56 fatal neurodegenerative 56 Ribavirin causes 56 fatal neuromuscular disorder 56 lysosomal storage disorders 56 Autoimmune diseases 56 tryptase 56 Eisenmenger syndrome 56 diagnostic biomarker 56 hypothalamic pituitary 56 pemphigus vulgaris 56 adenoviral 56 genetic determinants 56 TLR3 56 Genetic predisposition 56 epithelia 56 beta defensins 56 hepatoma 56 gastric carcinomas 56 LIS1 56 autophagic 56 secretory pathway 56 inherited retinal 56 anticancer treatments 56 MGUS 56 chromosomal rearrangement 56 Chronic pancreatitis 56 Fc receptor 56 PTPN# 56 glycosylated 56 glaucoma macular degeneration 56 alveolar epithelial cells 56 sonographic diagnosis 56 meningiomas 56 anticancer therapeutics 56 blood coagulation disorders 56 neuroligins 56 pediatric acute lymphoblastic 56 thalidomide Thalomid 56 K ras mutations 56 Gliomas 56 SOD1 56 TLR9 agonists 56 cholinergic neurons 56 TÎ ² 4 56 hematopoietic 56 debilitating neurodegenerative disorder 55 diagnostic biomarkers 55 PIK3CA 55 post transplant lymphoproliferative 55 neurodegenerative disease 55 GPC5 55 chronic autoimmune disorder 55 Crohn disease CD 55 rheumatic disease 55 autoimmune thyroiditis 55 histone modifications 55 phenotypes 55 neuropathies 55 colorectal adenocarcinoma 55 GIST tumors 55 pathogenesis 55 multiple sclerosis rheumatoid arthritis 55 urothelial cancer 55 hemolytic 55 vidofludimus 55 treating neuropathic pain 55 Behcet uveitis 55 environmental toxicants 55 iron chelators 55 metabolic abnormalities 55 dirucotide MBP# 55 herpes simplex viruses 55 tic disorders 55 Flt3 55 ventricular myocardium 55 kappa opioid receptors 55 embryonal 55 breast endometrial 55 chronic viral infections 55 Neurofibromatosis type 55 prion diseases 55 Peripheral neuropathy 55 protein isoforms 55 vaso occlusive crisis 55 BCR ABL mutations 55 dissociative disorders 55 T1DM 55 breast cancer subtypes 55 bone morphogenetic proteins BMPs 55 Atopic eczema 55 pleiotropic effects 55 common disabling neurological 55 mesenchymal cell 55 organogenesis 55 childhood leukemias 55 Prognostic factors 55 Fibroblasts 55 enteropathy 55 Immunotherapeutic 55 neoplasm 55 Eosinophils 55 antiangiogenic agent 55 intercellular signaling 55 exudative 55 leukaemias 55 somatic mutations 55 causative genes 55 squamous cell lung cancer 55 leukemia lymphomas 55 anticancer therapy 55 colony stimulating factors 55 HER2 overexpression 55 trigeminal 55 meningeal 55 Leber hereditary optic neuropathy 55 IL 1ß 55 myeloid 55 A3 adenosine receptor 55 heritable diseases 55 papillary renal cell carcinoma 55 clonally 55 glycolipid 55 bilaterians 55 aberrant activation 55 cardio renal 55 heritable disorders 55 connective tissue diseases 55 neoplasms 55 SOD1 gene 55 cardiometabolic disorders 55 retinal disorders 55 severe congenital neutropenia 55 Genetic variations 55 lymphoblasts 55 hypereosinophilic syndrome 55 mycosis fungoides 55 KRAS oncogene 55 skeletal metastases 55 pro angiogenic 55 sphingolipids 55 chronic granulomatous disease 55 MYH9 gene 55 dysregulation 55 chromosomal aberrations 55 telomerase activators 55 TLR antagonists 55 neoplastic cells 55 Fas ligand 55 epithelial barrier 55 retinitis pigmentosa RP 55 colorectal carcinoma 55 cisplatin resistant 55 neovascularization 55 malignant transformation 55 lysosomal 55 neurological disorder affecting 55 Pim kinases 55 gene rearrangements 55 muscle dystrophies 55 Cushing syndrome 55 retinal pigment epithelial 55 genitourinary cancers 55 diabetic kidney 55 inflammatory disorders 55 PKU genetic 55 cervical lymph nodes 55 neural cells 55 acetylcholine receptor 55 mutated K ras 55 neovascularisation 55 systemic lupus erythematosus 55 cystic fibrosis chronic pancreatitis 55 myoclonus 55 AT1R 55 pituitary adenomas 55 Bardet Biedl syndrome 55 metastatic lymph nodes 55 multisystem disease 55 cerebral palsy Down syndrome 55 enzymatic pathways 55 amyloidogenic 55 antisense inhibitors 55 sclerosing 55 retinal degenerations 55 C5aR 55 inherited neurological disorder 55 underlying molecular mechanisms 55 plexiform neurofibromas 55 HGPS 55 mastocytosis 55 trophoblasts 55 mental retardation epilepsy 55 Alpha lipoic acid 55 L. pneumophila 55 lysosomal enzyme 55 skeletal myoblasts 55 aneuploid cells 55 Congenital Muscular Dystrophy 55 Brodmann Area 55 Activating mutations 55 immune mediated 55 autosomal dominant disorder 55 C1q 55 JAK2 55 Lymphomas 55 Mitochondrial dysfunction 55 atopic disorders 55 SNT MC# 55 podocytes 55 Pervasive Developmental Disorders 55 mGluRs 55 Smad3 55 multiple sclerosis lupus 55 Lou Gehrigs disease 55 neuroinflammatory 55 developmental abnormalities 55 IL#R 55 molecular subtypes 55 basophils 55 telomere lengths 55 chromatin structure 55 highly vascularized 55 autosomal recessive 55 hematologic malignancies 55 glutamate signaling 55 leukoencephalopathy 55 Nitric oxide NO 55 #q# deletion 55 Tuberous sclerosis 55 humoral responses 55 GBMs 55 autosomal recessive disorder 55 lymphoid tissues 55 homozygous FH 55 chromosome rearrangements 55 pathophysiology 55 tyrosine kinase receptor 55 systemic lupus erythematosus SLE 55 coding genes 55 fibrosarcoma 55 mGluR5 antagonist 55 pathophysiological processes 55 protein kinase C 55 thyroid carcinoma 55 cortical dysplasia 55 respiratory gastrointestinal 55 mosaicism 55 kallikrein 55 renal tumors 55 physiologic mechanisms 55 nondemented 55 malignant lymphocytes 55 polycythemia vera essential thrombocythemia 55 cytopathic 55 erythropoietic 55 non Hodgkin lymphomas 55 monoclonal gammopathy 55 oligomeric 55 GPCR targets 55 anti angiogenic drugs 55 Aviptadil 55 Enkephalin 55 flaviviruses 55 unknown etiology 55 effector function 55 p# activation 55 EGFR HER2 55 PI3K Akt 55 potent inhibition 55 chronic hepatitis cirrhosis 55 proliferative diabetic retinopathy 55 tumor xenograft models 55 hereditary predisposition 55 Alzheimer disease cognitive impairment 55 interferon pathway 55 Dysregulation 55 p# mitogen activated 55 genetic loci 55 cell signaling pathways 55 VEGF inhibitors 55 tissue fibrosis 55 MMP inhibitors 55 uricase 55 KCNH2 55 ADAM# 55 Candida infection 55 ADAMTS# 55 JAK mutations 55 Th2 cytokines 55 Hedgehog signaling 55 Wnt signaling pathway 55 amnestic 55 chromosome aberrations 55 pDCs 55 antibody mediated 55 MELAS 54 folate metabolism 54 HSF1 54 generalized seizures 54 #beta HSD1 54 γδ T cells 54 xeroderma pigmentosum 54 LRP5 54 transgenic rats 54 receptor inhibitor 54 Alzheimer Disease Parkinson Disease 54 serine protease 54 acne rosacea 54 GRNCM1 54 nephrogenic 54 potent antiproliferative 54 Basal cell 54 epiglottitis 54 skeletal muscle weakness 54 Friedreich ataxia 54 Severe Primary IGFD 54 cell adhesion molecules 54 cardiac fibroblasts 54 PsA 54 alpha2 54 Weinstock Guttman 54 HIF PHIs 54 noncoding RNAs 54 sarcomas 54 ESBA# 54 Beta thalassemia 54 somatostatin 54 alpha interferons 54 fascin 54 cystic fibrosis transmembrane 54 ophthalmologic disorders 54 RNA antagonist 54 paragangliomas 54 transmembrane receptor 54 therapeutically useful 54 Carcinoid tumors 54 NADPH oxidase 54 potent inducer 54 adult neurogenesis 54 sialic acids 54 lymphoid 54 clinicopathologic 54 leukocyte adhesion 54 induce pluripotency 54 dopaminergic 54 chronic inflammations 54 neurocognitive deficits 54 asplenia 54 hematological abnormalities 54 rxRNA compounds 54 ERK1 2 54 NTDDS 54 Granulocyte Colony Stimulating Factor 54 lipoprotein metabolism 54 eicosanoids 54 endocrine therapies 54 pharmacological chaperone 54 neuronal differentiation 54 viral hemorrhagic fevers 54 comorbid anxiety 54 adenomatous 54 CIDP 54 chromosomal translocations 54 Inflammatory bowel disease 54 neuro developmental disorders 54 liver cancers TTR 54 cognitive dysfunction 54 Tß4 54 brain lesions 54 disorders 54 LPM TM 54 ultrastructure 54 gonococcal 54 miR #a [001] 54 Leber Hereditary Optic Neuropathy 54 retinal diseases 54 causal pathways 54 cytopenias 54 glucocorticoid receptors 54 transferrin receptors 54 carcinoid tumors 54 BRAF V#E 54 HuMax HepC 54 pancreatic neuroendocrine 54 geographic atrophy 54 Squalamine 54 demyelinated 54 nAChR 54 HER2 positive cancers 54 pancreatic islet 54 nonmelanoma skin cancers 54 Sjogren Syndrome 54 Henoch purpura 54 haemolytic anemia 54 Atopic dermatitis 54 Anaplastic 54 steatohepatitis 54 Evoltra ® 54 Meckel Gruber syndrome 54 neurocognitive impairment 54 diabetes mellitus DM 54 striated muscle 54 immune modulator 54 endocrine glands 54 diabetic retinopathy DR 54 hepatic stellate cells 54 cytokine receptors 54 Cockayne syndrome 54 cyclophilin inhibitors 54 ABCB1 54 Myasthenia gravis 54 adrenal cortex 54 liver cancers hypercholesterolemia 54 peroxisomal 54 immunosuppressed patients 54 immunocompromised individuals 54 cAMP signaling 54 Nonalcoholic fatty liver 54 microsatellite instability 54 Diffuse Large B 54 STAT4 54 chronic myeloid 54 γ secretase 54 intestinal microflora 54 monomeric 54 sphingolipid 54 treating cancerous tumors 54 sequence homology 54 lymphatic vasculature 54 M2 subunit 54 humanized monoclonal antibodies 54 oculomotor 54 PDE#A 54 TPMT 54 degenerative retinal diseases 54 astrocytic 54 clinico pathological 54 aneuploidies 54 vacuolar 54 Iron deficiency anemia 54 #HT#A 54 primary hyperparathyroidism 54 Pseudomonas aeruginosa infections 54 benign moles 54 dysmotility 54 hematopoietic progenitor cells 54 Dr. Ivashkiv 54 CD8 + 54 radiotherapeutic 54 autoimmune uveitis